⌘K
Loading ticker…
CervoMed Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, CervoMed Inc. Common Stock (CRVO) has a 3-month relative strength percentile of 25 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 22.3%, relative volume 0.02×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
25 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CRVO is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $986K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $986K |
| VXFVanguard Extended Market ETF | 0.00% | $260K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRVO Jan avg: -9.64% median: -3.42% win: 33% σ: 22.71% n: 3 2023-08-18 → 2026-05-29 | CRVO Feb avg: 13.74% median: -0.89% win: 33% σ: 45.38% n: 3 2023-08-18 → 2026-05-29 | CRVO Mar avg: 125.64% median: 69.70% win: 67% σ: 162.27% n: 3 2023-08-18 → 2026-05-29 | CRVO Apr avg: -1.03% median: -0.98% win: 33% σ: 5.30% n: 3 2023-08-18 → 2026-05-29 | CRVO May avg: -19.35% median: -20.31% win: 0% σ: 3.26% n: 3 2023-08-18 → 2026-05-29 | CRVO Jun avg: -11.28% median: -11.28% win: 0% σ: 2.36% n: 2 2023-08-18 → 2026-05-29 (current) | CRVO Jul avg: 3.60% median: 3.60% win: 50% σ: 39.12% n: 2 2023-08-18 → 2026-05-29 | CRVO Aug avg: 12.61% median: 16.61% win: 67% σ: 32.80% n: 3 2023-08-18 → 2026-05-29 | CRVO Sep avg: -19.82% median: -21.59% win: 0% σ: 3.39% n: 3 2023-08-18 → 2026-05-29 | CRVO Oct avg: 22.62% median: -6.51% win: 33% σ: 56.04% n: 3 2023-08-18 → 2026-05-29 | CRVO Nov avg: 11.14% median: 13.30% win: 67% σ: 30.99% n: 3 2023-08-18 → 2026-05-29 | CRVO Dec avg: -40.33% median: -22.14% win: 0% σ: 32.92% n: 3 2023-08-18 → 2026-05-29 |